Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss

Publication Type
Conference Paper
Year of Publication
2005
Authors
Aiello, LP; Vignati, L; Sheetz, MJ; Zhi, X; Girach, A; Davis, MD; Milton, RC; The PKC DRS2 Study Group
Secondary
13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG)
Date Published
27/09/2005
Location
Berlin, Germany
URL
http://www.dog2005.org/images/soe_dog_programme_2005.pdf